Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-08-026175
Filing Date
2008-05-06
Accepted
2008-05-05 21:57:23
Documents
7
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 v110520_10k.htm 10-K 3502590
2 GRAPHIC line.gif GRAPHIC 43
3 GRAPHIC spacer.gif GRAPHIC 43
4 v110520_ex23.htm EX-23 3507
5 v110520_ex31-1.htm EX-31.1 11524
6 v110520_ex31-2.htm EX-31.2 12502
7 v110520_ex32.htm EX-32 11194
  Complete submission text file 0001144204-08-026175.txt   3543162
Mailing Address 1635 VILLAGE CENTER CIRCLE SUITE 250 LAS VEGAS NV 89134
Business Address 1635 VILLAGE CENTER CIRCLE SUITE 250 LAS VEGAS NV 89134 702-248-1174
CardioVascular BioTherapeutics, Inc. (Filer) CIK: 0001303497 (see all company filings)

EIN.: 330795984 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-51172 | Film No.: 08804462
SIC: 2834 Pharmaceutical Preparations